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Abstract
Background: While current cannabis research has advanced our understanding into the effects of its individual
components, there is a pressing need to identify simple terminology that is understood in the same way by researchers and
users of cannabis. Current categorisation in research focuses on the two main cannabinoids: delta-9-tetrahydrocannabinol
(THC) and cannabidiol (CBD); and two different species of cannabis: indica and sativa. Recreational cannabis has also been
categorised by researchers as ‘skunk’ or ‘hash’. Focusing on individuals who use cannabis frequently, this study aimed to
identify views on current terms used to denote different types of cannabis and to identify terms validated by participants.
These views were extracted from responses of the Cannabis Experiences Questionnaire (CEQ), a widely used instrument in
the literature.
Methods:We qualitatively analysed 236 free-text responses from Question 23 of the CEQ survey (using Iterative
Categorisation) relating to categorization and consumption methods. Data was used from a previous study (Sami
et al., Psychol Med 49:103–12, 2019), which recruited a convenience sample of 1231 participants aged 18 years
and above who had previously used cannabis.
Results: Regarding type of cannabis used, specific strain names (n = 130), concentrates (n = 37), indica/sativa (n = 22)
and THC/CBD terms (n = 22) were mentioned. Other terms used were hybrids (n = 10), origins of specific strains (n =
17), edibles (n = 8), and herbal cannabis (n = 7). Regarding problems with specific terms, participants were skeptical
about terms such as skunk and super skunk (n = 78) preferring terms like THC/CBD, indica/sativa, specific marketed
strains and references to preparation methods.
Conclusions: The results suggest a disparity between the common terms used by researchers in academia and those
used by cannabis consumers. While there are advantages and limitations of using these terms to bridge views of
researchers and individuals who use cannabis, this study underscores the importance of formally assessing chemical
constituents rather than relying on self-report data and of incorporating cannabis user views on current terms used in
research, potentially also incorporating descriptors of preparation and consumption methods.
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Background
Cannabis is one of the most widely cultivated psychoactive
drugs consumed by 3.9% of the global population aged
15–64 years old World Drug Report (2020). Cannabis has
over 120 different cannabinoid compounds (specific to
cannabis) with over 600 different terpenoids and flavo-
noids (Ahmed et al. 2015; Radwan et al. 2015). The two
primary cannabinoids that are most abundant in common
cannabis strains are: delta-9-tetrahydrocannabinol (THC)
and cannabidiol (CBD). Human experimental studies have
shown that acutely both THC and CBD may have oppos-
ing effects on behaviour and cognition (Bhattacharyya
et al. 2010; Colizzi and Bhattacharyya 2017; Hindocha
et al. 2015). Following chronic exposure or repeated dos-
ing, THC may increase the risk of onset and relapse of
psychosis, while CBD may oppose its harmful effects
(Morgan and Curran 2008; Schoeler et al. 2016) and have
antipsychotic effects (Schoevers et al. 2020) with good tol-
erability (Iffland and Grotenhermen 2017).
Due to the opposing health effects seen with different
cannabinoids, recent research has moved from treating
cannabis as one entity to a more fine-grained under-
standing. This includes measuring the concentration of
cannabinoids, particularly THC and CBD (Englund et al.
2017; Morgan and Curran 2008). Botanists have com-
bined this research of cannabinoids with their focus on
morphological distinctions (Clarke and Merlin 2016) to
categorise cannabis types into two species: sativa and
indica (Piomelli and Russo 2016). Cannabis sativa often
has lower levels of THC to CBD, compared to cannabis
indica, presenting with higher levels of THC (Clarke and
Merlin 2016; Hillig and Mahlberg 2004). It is possible to
crossbreed cannabis plants to contain both indica and
sativa characteristics, producing strains known as hy-
brids, potentially affecting the validity of such
categorization (Piomelli and Russo 2016). Market strain
names (such as ‘Haze’) that are bought by individuals
who recreationally use cannabis are usually described
based on their species and THC content. As well as
these more detailed outlooks, research has also focused
on how the method of preparation and consumption al-
ters the effects of cannabis. Methods such as ‘vaping’
(Budney et al. 2015) and ‘blasting’, where products such
as ‘shatter’, ‘wax’ or ‘dabs’ are consumed can cause prod-
ucts originating from the same plant to often have dis-
similar effects (Stogner and Miller 2015a) due to
variability in the amount of THC and the rate at which
it may be consumed through different methods (Stogner
and Miller 2015b). Therefore, how cannabis is consumed
may also influence its effects apart from the concentra-
tion of different cannabinoids.
Self-report measurements have been used to examine
detailed responses on the type of cannabis used by par-
ticipants (The Medical Marijuana Patient Use
Questionnaire, Bonn-Miller et al. 2014; Cannabis Experi-
ence Questionnaire, (Barkus et al. 2006) and the motives
underlying use (Connor et al. 2011). The Cannabis Ex-
perience Questionnaire, on which several findings have
been based (CEQ, Di Forti et al. 2009; Di Forti et al.
2015; Sami et al. 2019; Schoeler et al. 2016; Quinn et al.
2017) uses the terminology resin/dried plant, herbal can-
nabis (outdoor grown) and sinsimilla/skunk. Skunk is a
non-pollinated seedless cannabis plant (Freeman and
Winstock 2015), grown indoors in highly controlled con-
ditions (Potter et al. 2008), and high in THC (THC at
1–23%; Potter et al. 2008). Herbal cannabis also contains
high THC levels (9%; Freeman and Winstock 2015) and
low CBD (below 0.1%; Potter et al. 2008).
However, terminology used in research reports often
neglect terms like indica/sativa, THC/CBD or descrip-
tion of the specific preparation and/or consumption
methods when asking users of cannabis about their
drug-induced experiences. Furthermore, it remains un-
clear whether terms such as ‘skunk’ often used in re-
search focusing on police seizures of cannabis (Englund
et al. 2017) are used by recreational cannabis users
themselves to describe the specific type of cannabis that
they may seek for use. As self-report data is often relied
upon to understand the psychological effects of drug-
induced experiences (Hardwick and King 2008; Potter
et al. 2008) in the content of cannabis use, it is particu-
larly important to align terminology, such that re-
searchers and individuals who use cannabis employ
terms that have the same meaning or refer to the same
thing. In the absence of a common set of terms used to
describe different types of cannabis by both researchers
and people who use cannabis, respondents of question-
naires describing experiences associated with the use of
different types of cannabis use may be referring to some-
thing completely different from how researchers inter-
pret their responses, affecting the usefulness and validity
of much painstaking work.
Therefore, the aims of this exploratory study were to
aid in the development of common language to describe
cannabis related terms used by both the cannabis user
and researcher, increasing methodological validity of fu-
ture cannabis research. Cannabis terminology in this
study relates to terms used to describe different types of
cannabis products and not legal categories as described
under the Misuse of Drugs Act 1971.The objectives were
(1) to identify views of experienced users of cannabis on
current terms used to describe different types of canna-
bis used recreationally and (2) to identify terms that
were validated by the respondents. These aims were
achieved by qualitatively analysing the responses from
the Cannabis Experience Questionnaire, focusing on
consumption method, type of cannabis smoked and rea-
sons for consuming their choice.
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Methods
Following ethical approval from the Kings College,
London Research Ethics Committee (REMAS HR-14/15-
0551), a web-based survey based on a modified version
of the Cannabis Experiences Questionnaire (Barkus et al.
2006) was carried out. Participants were given an infor-
mation sheet online and were asked to sign an online
consent for (as required by the ethics committee) before
they were able to take part in the survey. The survey was
available to members of the public aged 18 and over,
and data was collected between December 2015 and
September 2016. Participants were recruited through
advertising from the King’s College London mailing list,
as well as through social media sites (like Facebook,
Tumblr and Twitter), given the opportunity to enter into
a raffle of three prizes worth £10–£50 on completion of
the questionnaire. Requests were made through social
media with cannabis campaigning organisations, includ-
ing the London Cannabis Club and CLEARUK to pro-
mote the study. The questionnaire was primarily used to
collect data on cannabis use. We planned to address the
main objectives once the data collection has ended.
Using data collected from this survey, we have previ-
ously examined the association between psychotic-like
experiences associated with cannabis use and cessation
of cannabis use in a previous manuscript (Sami et al.
2019). The present study focuses on previously unre-
ported data from the survey, specifically questions re-
garding the method of cannabis consumed, type and
reason for this.
CEQ questionnaire
The survey was based upon an instrument developed in
Manchester and Wollagong (Barkus et al. 2006; Barkus and
Lewis 2008) finding widespread use by researchers across
populations over the last decade (Barkus and Lewis 2008;
Bianconi et al. 2016; Quinn et al. 2017). This questionnaire is
a 46-item self-report scale focusing on frequency/pattern of
use, age and type of use. The experience subscales are di-
vided into pleasurable, psychosis-like and after-effect experi-
ences (Barkus and Lewis 2008).
The survey used mixed methods including Likert
scales for cannabis experiences and categorical responses
to determine demographic data. Regarding the type and
method of cannabis consumed, the survey asked the fol-
lowing question:
(i) What type of cannabis do you use the most:
– Hash (cannabis resin/solid)
– Imported herbal cannabis
– Homegrown skunk (sinsimilla)
– Superskunk
– Synthetic cannabis (such as spice or black
mamba)
– Other (please specify) if there are names of
brands please also specify: (free-text)
Qualitative analysis method
Qualitative analysis of all free-text responses was under-
taken by a postgraduate psychology student (AM) super-
vised by qualitative methodologist (CN). These responses
were in the free-text response mentioned earlier; the
‘other’ option regarding cannabis type consumed. Meth-
odology followed was that of Iterative categorisation
(Neale 2016), a systematic approach combining deductive
and inductive coding specifically developed for analysis of
qualitative data within the addictions research field. De-
ductive codes were developed through team discussion a
priori, supplemented by inductive generation of ‘in vivo’
codes derived from the data (Neale 2016).
Prior to analysis, a deductive coding data file was de-
veloped to incorporate all responses. Inductive coding
was generated, working line by line through the content
of each free-text response. Responses were categorised
by type of cannabis consumed views of respondents on
current terms, terms validated by individuals who use
cannabis and information about the marketed strain
sources. The second step involved constructing a coding
file, where the inductively derived codes were matched
to the deductive coding file initially created. This was
then condensed to an ‘enablers’ file (Additional file 1:
Appendix 1), where similar responses were grouped to-
gether per coding category. Lastly, a summarised analysis
file (Additional file 1: Appendix 2) was created to inter-
pret the responses from each category. Analysis was dis-
cussed and agreed as a team throughout the process.
Results
Demographics
There were 1425 individuals who responded to the sur-
vey, including responses from 1231 individuals who had
used cannabis at least once and 926 current cannabis
users. One thousand one hundred seven participants
provided any form of qualitative answers, i.e., they filled
in any of the free-text boxes related to the reasons for
their cannabis use or changes in use. Two hundred
thirty-six (16.5%) participants provided qualitative an-
swers for the CEQ question “What type of cannabis do
you use the most” in the ‘other’ free-text response.
68.7% of respondents were male with an average age
of 29.5 years (s.d. 10.3 years). Although the country of
respondents was not routinely asked during the study,
531 participants agreed to a follow-up study and gave
their place of residence. Four hundred ninety-four (93%)
participants lived in the UK and 23 (4.3%) from Sweden.
There were also a few responses from Brazil, Greece,
Mauritius, the USA and Zimbabwe. 38.1% of the respon-
dents reported previous mental health contact. While
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the free-text information did not quantify this, it ap-
peared to be related to depression, anxiety or stressful
experience and treatment by counselling or a primary
care setting. Regarding cannabis use, mean age of first
use was 16.7 years (ranging from 7 to 55 years old).
75.2% of participants continued to use cannabis, with
18.4% agreeing they would stop in the future. Regarding
frequency of cannabis use, 44.4% of participants used
cannabis every day, 22% used it more than once a week,
13.2% used it a few times a month, 10.7% a few times a
year and 5.6% once or twice generally. 4.1% of the data
was missing for this question.
Quantitative analysis of response frequency
From 236 free-text responses regarding type of cannabis used
most commonly, 21 different themes/terms emerged as
mentioned in the comments (350 total references, as some
responses mentioned more than one theme). Regarding type
of cannabis used, specific strain names were mentioned most
frequently (130 out of 350 references), the most popular be-
ing Haze (46 out of 350), Cheese (27 out of 350) and Kush
(19 out of 350). Other common cannabis types referred to
were concentrates (37 out of 350; including ‘concentrate’,
resin, dabs, wax, BHO/butane and shatter), indica/sativa (22
out of 350) and THC/CBD terms (22 out of 35). Terms such
as hybrids (10 out of 350), strain origins (17 out of 350), edi-
bles (8 out of 350) and herbal cannabis (7 out of 350) were
mentioned less frequently. Out of all the participants (n=
236) who filled out free-text responses via the text box, 98
participants expressed dissent about the terms used by re-
searchers to commonly describe types/categories of cannabis
in their free-text responses regarding type of cannabis used.
Participants most commonly expressed concern with use of
the terms skunk and superskunk (78 out of 350) to describe
cannabis categories. Less frequently, concern was expressed
about the terms sinsemilla (7 out of 350), synthetic (5 out of
350), imported (5 out of 350) and homegrown (3 out of 350)
used to describe cannabis types.
Qualitative analysis
Two over-arching themes were examined from the
qualitative analysis: (1) views of respondents on current
terms and (2) terms validated by experienced cannabis
users. Regarding the first theme, terms that respondents
commented on were sinsemilla, homegrown, synthetic,
imported and skunk/super skunk. However, a significant
amount of responses related solely to the terms skunk/
super skunk. Focusing on these terms, responses sug-
gested that these terms were (i) unknown and undefined,
(ii) incorrectly applied terms from the media, (iii) used
to describe a wide range of market strain names and (iv)
outdated terms referring to high THC levels.
Responses relating to the second theme ‘user-validated
terms’ were categorised into (i) THC and CBD (ii)
indica/sativa. (iii) Popular marketed strains and (iv) dif-
ferent preparation methods.
Theme 1: views of respondents on the current terms; skunk/
superskunk
(1i) Terms are unknown and not clearly defined Par-
ticipants reported these terms as not clearly defined or
well-known terms. As many of these participants consid-
ered themselves to be frequent users of cannabis, they
seemed certain that these terms were not in common
use amongst cannabis users or that their existence was a
‘myth’. Example responses from participants in this cat-
egory were the following:
 ‘What is homegrown skunk or super skunk- need to
get terminology right before publishing.’
 ‘What is super skunk? This terminology is
unfamiliar to me - and I talk to a lot of cannabis
users it really should be familiar.’
 ‘I smoke strong home grown weed, there is no such
thing as “skunk” or “super skunk” in the real world.’
 ‘Don't entirely understand the names given above. I
mostly smoke marijuana (skunk?), either home
grown by my friends and/or dealers or imported
from abroad. Not sure what “super skunk” is.’
(1ii) These terms are often used in the media, not
scientific surveys One of the comments paired with the
terms being unrecognised was their use in the media.
Specifically, ‘skunk’ was seen as unacceptable and more
a ‘buzzword’ that should not be used in a scientific set-
ting. Some responses stated that the media use this word
to signify ‘well grown cannabis plants’ or ‘the flower of
the plant’. While all these responses suggested a negative
view on media use, some went on further to say that use
of these ‘buzzwords’ causes individuals who use cannabis
to lean heavily away from these terms. These responses
can be seen below:
 ‘Don’t know what you mean by skunk/super skunk.
If you mean do I smoke the flower of the plant then
yes but that doesn’t necessarily mean that its skunk.
Not all cannabis flowers are skunk. Maybe do some
research instead of using terminology used in the
media. Especially if you’re going to run a survey’.
 ‘Amongst ‘experienced’ users, ‘skunk’ is not a
recognised term-there is not a consensus on what
exactly it is and the media over-using it as a buzz-
word causes us to lean heavily away from the term.’
 ‘By ‘super skunk’ I assume you’re just referring to
what the media call skunk, aka well grown cannabis
plants..?’
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 ‘Inadequate- super skunk/skunk not acceptable
terms- used solely by the media to promote
cannabis.’
(1iii) These terms rarely reported by consumers are
being used to generalise a wide range of market
strain names Participants suggested that using the term
skunk portrayed a lack of awareness of different mar-
keted strains that were available. Responses also stated
that this specific strain should not be highlighted as a
main categorisation method, as it is not the main strain
consumed by individuals who frequently use cannabis.
This suggested perhaps a lack of understanding of the
complexity of strains available and need on the part of
researchers to reflect that in terms used to denote differ-
ent types of cannabis strains available for recreational
use. Examples of these responses can be seen below:
 “There are a thousand and one strains available.
Skunk is one of them. It's like calling your vacuum
cleaner a Hoover even if it’s made by Dyson.”
 ‘Skunk is a specific strain, not a “type of cannabis”.
This is like asking “what type of alcohol do you use
mostly? Vodka or Gin”. This question is
fundamentally flawed for the information you are
trying to get.’
 ‘I'm sorry: The terminology you have used makes it
impossible to answer the question. “Skunk” is a
single strain or small grouping of strains only, when
there are 100s od strains that are not “Skunk”.
(1iv) Overused and outdated term referring to THC
levels Respondents also stated that the terms skunk and
super skunk were often paired with THC levels that
could be seen as terminology method in itself. Responses
stated this was invalid as skunk itself is not strong and
may not have significantly higher THC levels compared
to other strains. This can be seen in the below
responses:
 ‘Firstly, most dealers don’t have a clue whether the
cannabis was imported or home grown and fewer
tell the customer. Secondly, what on earth is super
skunk? If you do a little bit of reading and see how
cannabis is bred you will know skunk as you call it
doesn’t exist! That name being applied to high THC
cannabis is plain wrong’
 ‘Skunk and super skunk I find derogatory terms used
to describe cannabis with low cbd content and a
higher thc content. It’s like describing a bottle of
chateau rothschild like a bottle of lambrini. I use
none of the above but I do use a good quality
cannabis not from the street’.
 ‘I can only assume you are using the terribly
inaccurate and misleading media term of cannabis
that contains very high levels of THC and very low
levels of CBD. Skunk itself it actually not that strong
at all.’
Theme 2: terminology mentioned by the respondents
(2i) THC and CBD One alternative method of categor-
isation that was suggested seemed to be based on THC/
CBD ratio. Conflicting responses were found referring to
the ratio preferences of THC:CBD, with some showing
no preference or favouring a 1:1 ratio. Other participants
specified a preference for higher CBD to THC, contrast-
ing responses preferring high sativa skunk with higher
THC levels.
This was also connected to the method of preparation
and consumption, with responses stating that cannabis oil
has a ‘better balance of CBD to THC’, mentioning its use
for THC wax (concentrated THC smoked off a vaporising
pin) and use in pill form (500 mg CBD). Market strain
names and indica/sativa terms were also paired with
THC/CBD terms, suggesting a link to other terms that
could also be used as valid terminology.
One participant stated that people who use cannabis
needed to be responsible enough to know the difference
between use and abuse when using high THC marketed
strains. This suggests the importance of the actual ap-
proach and use of cannabis in relation to the chemical
constituents consumed. While there were differing views
on THC:CBD ratio preference and its paired terms, it
was seen by participants as a means of identifying and
categorising cannabis strains.
 ‘1:1 ratio THC/CBD Indica strains’.
 ‘The weed I buy is mostly sativa but now and again I
go for an indica. It probably has a fairly high THC/
CBD ratio as the buds a well formed and have a
good coating of trichomes’.
 ‘Girl scout cookies indica over 20% thc low cbd.
Pineapple express over 22% thc’.
 ‘High sativa skunk preferred as has good THC level.’
 Consumes cannabis oil- THC wax, concentrated
THC smoked off a vaporising pin [p28].
 ‘I prefer less of the THC and more of the CBD in a
strain that is what seems to give me the most
effective medicinal/pain relieving properties’.
 ‘Likes other strong/high THC strains you need to be
responsible to know the difference between use and
abuse’.
(2ii) Indica/sativa Another term raised almost as fre-
quently as THC/CBD was indica and sativa. When men-
tioned, general preference was usually for indica, with
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both indica and sativa stated as helpful for medical pur-
poses. Like THC/CBD, this phrase was often paired with
a marketed strain term. Additionally, hybrids (a mixture
of sativa and indica variants) were often mentioned.
These responses (shown below) point towards a view
that cannabis plant species may be considered by indi-
viduals who use cannabis as a viable categorization
method.
 ‘There are two different types of cannabis: indica
and sativa’.
 ‘There are many different cannabis strains eg. Blue
Cheese, Afghan Kush, Silver haze. There is also two
different types of cannabis, indica and sativa. The
tick boxes are not adequate’.
 ‘I normally try to find an indica that’s got a good
amount of CBD. I have back pain and constant
sciatica. It's excellent as a muscle relaxant and helps
as a sleep aid’.
 ‘Sativa heavy hybrids are what they like the most,
such as Jack Herer perfect for medical and
recreational purposes’.
 ‘Uses Jack Herer- an indica dominant hybrid made
by combining shiva skunk (indica) and northern
lights (indica)’.
(2iii) Popular marketed strains Instead of terms like
skunk and THC/CBD used in addiction research, mar-
keted strains were most frequently mentioned in the
free-text response of cannabis type used. Frequently
mentioned strain names were various Hazes, Kush and
Cheese strains. In this sample, Lemon haze was the most
frequently mentioned strain consumed, followed by am-
nesia haze, super silver haze and other hazes; grapefruit,
Abyssinia, mango, silver haze, super bubblegum and
golden haze. In terms of strength, participants men-
tioned general haze to be far stronger than other strains
such as super Skunk, specifically mentioning super silver
haze and super lemon haze.
Consumption of cheese strains was another frequently
mentioned response, with participants stating it was
mainly common in England and seen as highly regarded
to get a ‘high’. Different cheeses mentioned were Blue
(seen as the strongest), Dutch and Buddha cheese. Six
participants consumed Jack Herer, (described as an
indica dominant hybrid), combining Shiva skunk with
Northern lights indica strain. Jack Herer was utilised for
medical (particularly pain-relief) and recreational pur-
poses and helps with energy levels. The frequency of re-
sponses relating to each strain name can be found in
Additional file 1: Appendix 3.
(2iv) Alternative preparations concentrates/oils/
edibles Vaping and dabbing (formerly mentioned in the
introduction) were noted in the free-text response to be
newer methods of consumption not included in the
current survey, with other excluded options being con-
suming shatter, crumble and wax. A variety of oils were
mentioned for example chocolate infused hash oil and
various CBD oils. Edibles mentioned included infused
coconut oil (seen as an appetite stimulant), butter weed
with coffee (seen as relaxing), cannabis butter with
already vaped herbs and hash infused chocolate. Consid-
ering the wide range of consumption methods as well as
the effect these may have on the user’s experience sug-
gest the need to add these newer methods to current
terminology. The range of responses can be seen below:
 ‘Question is idiotic and misinformed, as are a few of
the others already answered (no option for
vaporising/dabbing in method of consumption
question)’.
 ‘The survey is incomplete- either vape medical weed
or concentrates, oil, shatter, wax in vaporiser not
smoking at all’.
 ‘Butter weed with coffee= relaxing’.
 ‘Wax, shatter and concentrates are also widely used,
but too much money (£40-100 per gram) too strong
for me and builds dependency and tolerance levels’.
 ‘Then I make cannabis butter with the already vaped
herbs and coconut oil, this makes a great muscle
relaxant, painkiller, anti-depressant and appetite
stimulant’.
 ‘Not quite sure what type of cannabis I smoke-
almost all through a vape pen heating up cannabis
oil which is then inhaled better than inhaling smoke
from flames’.
Discussion
In this exploratory study, we analysed qualitative re-
sponses of individuals who were experienced users of
cannabis with regard to their views on terms used in the
academic setting to describe cannabis. The results may
suggest a potential disconnect between the common
terms used by researchers to denote different types of
cannabis and those used by cannabis consumers. Re-
garding the first aim, a sizeable proportion (around 40%)
of those providing free-text responses indicated disagree-
ment with the common terms used in research contexts
to denote various types of cannabis. To a large extent,
this disagreement was about use of the terms ‘skunk’ or
‘superskunk’. Views were that these terms were seen as
incorrectly applied to cannabis with high THC levels
and a wide range of marketed strain names in both the
research setting and in media reports. Secondly, terms
validated by respondents that were also used in research
were THC/CBD and indica/sativa. Other terms that
were also deemed as important to respondents were of
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marketed strain names, e.g. ‘haze’ and terms that re-
ferred to different methods of preparation of cannabis
for use. This underscores the importance of involving
cannabis users in the development of assessments for
assessing cannabis use and its effects. Common terms
used by both researchers and individuals who use canna-
bis often could include focusing specifically on THC/
CBD and indica/sativa terms and always including a
question on the preparation method used.
When considering the strong opinions raised towards
the term ‘skunk’, it is important to review the contextual
history of its use. Potter and Chatwin (2012) have stated
that the term ‘skunk’ originally had a precise meaning,
relating to indoor-grown, high potency marketed strain.
It has now been established in public discourse, in the
media and by policy makers and academics to encom-
pass a broad definition of a larger cannabis subset. Many
participants in the present study indicated that the term
generalises to a wide range of marketed strain names
and should not be used as one of the key terms to cat-
egorise different types of cannabis. This is consistent
with the idea that the term may convey different mean-
ings to different individuals and may generalise a specific
marketed strain to also refer to adulterated cannabis.
Two other key themes raised by respondents suggested
that skunk is often paired with high THC levels and is
an overused term used in the media. This mirrors com-
ments by Stevens (2007) that the term has often been
used in a pejorative sense to indicate excessive use of
high potency cannabis. Responses in the present survey
also seem to mirror participants’ responses obtained in
the survey carried out by Potter and Chatwin (2012) as
part of their qualitative analysis on cannabis classifica-
tion. The views generated by the term ‘skunk’ perhaps
may also indicate a distrust in the mind of some canna-
bis users that views of researchers about cannabis may
potentially be coloured by prejudice. This may be due to
the term inadvertently reinforcing existing media myths
as well as due to the lack of a shared precise term mean-
ing. Therefore, it may be the case that excessive use of
this once precise term may have caused its original
meaning to be lost and increased distrust in people who
use cannabis frequently. This may have a general nega-
tive effect on participants who may be put off by re-
search simply due to the use of terms like ‘skunk’,
underscoring the importance of public involvement in
understanding cannabis terminology to ensure that
terms used are deemed credible by both people who use
cannabis and researchers. However, it is also important
to put this in perspective in that a relatively modest pro-
portion of participants in the survey provided free-text
responses regarding type of cannabis used, of whom less
than half expressed negative views about the term
‘skunk’.
Relating to the second aim, terms mentioned by re-
spondents that were deemed as credible were those
based on THC/CBD ratio and indica/sativa strains. Both
these terms are used by researchers and botanists (Hillig
and Mahlberg 2004; Holland and Torres 2019), and sug-
gest the importance of reporting THC and CBD concen-
trations within the field of cannabis research. While
these responses may suggest that these are valid
methods of categorization, there are issues with the
terms indica/sativa. In particular, considerable inter-
breeding and hybridization may have rendered any at-
tempts at categorization based on physical properties of
the plant (such as branching, height, leaf morphology)
prone to errors and of limited utility in the absence of
biochemical assays (Piomelli and Russo 2016). Other ter-
minology highlighted by respondents was the manner in
which cannabis was prepared and consumed. Examples
of this would be vaping, dabbing, edibles through in-
fused oils, coffee, butter and chocolate. Method of con-
sumption is particularly important when considering
how cannabis with high THC concentration may be pre-
pared and consumed in a specific way by cannabis users
(Kilmer et al. 2013). This makes it harder to compare re-
sults from different academic studies or generalise these
results to cannabis use in the general population when
consumption methods may differ. Referencing consump-
tion method also is useful in that, while participants may
be unaware of the THC levels or specific strain con-
sumed, they will have direct knowledge of the way they
consume it. Therefore, including description of the con-
sumption method in research could increase the validity
of research particularly when generalising such results to
the wider cannabis user population.
Terms mentioned by respondents that are not often
used in research were specific marketed strain names.
While internet databases often describe psychological
characteristics and biochemical measurements of specific
marketed strains (Leafly 2020), these terms are rarely
used by academics. The reason for this may relate to all
the variables that could interfere with the results’ valid-
ity. Each strain comes with a wide range of subjective
experiences, perhaps due to different production com-
panies selling seeds and strains between each other,
affecting the characteristics of what is labelled as the
same strain. Availability of strains is also susceptible to
changes in consumer demand, thereby limiting the use-
fulness and reliability of marketed strain names over
time as standard terminology. Also, specific strain names
are inaccessible to researchers, meaning researchers
would be relying solely on feedback from users. Englund
et al. (2017) suggested that future methods of strain ac-
cess could be to collect joints of specific strains from in-
dividuals who use cannabis and test their cannabinoid
concentration. However, cannabis sample collection is
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expensive, yet to be validated and is challenging to do in
certain geographical jurisdictions because of legal impli-
cations (e.g. in the USA). It is important that the method
used is seen as unbiased to the cannabis user, reflective
of actual usage as well as feasible to be applied by the
academic and botanist. Therefore, use of marketed strain
terms as a method of categorisation may have limited
utility in the research context until such strains could be
accessed for research.
In light of this, it is also important to consider the
sample of participants who responded to this survey.
Our sample reflected the views of more experienced
cannabis users, who may have different opinions on
terms used to refer to various types of cannabis used
recreationally due to their greater knowledge and aware-
ness of the effects of cannabis containing different com-
binations of cannabinoids. Individuals who use cannabis
less frequently may have less familiarity with some of
the terms suggested before (such as THC/CBD or
indica/sativa). Therefore, in order to ensure appropriate
use of such terms in the context of research on cannabis
use, they may need to be tailored to target participants.
Further, it is worth noting that out of over 1100 respon-
dents who provided any free-text responses, only 236
participants provided responses regarding type of canna-
bis used, indicating that such views may not necessarily
fully represent the views of the wider population of can-
nabis users. Additionally, it is important to highlight that
most respondents of the present survey lived in the UK
and therefore results presented herein may not reflect
opinions of cannabis users residing in other countries.
This may reflect the need for considering regional vari-
ation of terms used to refer to different types/ categories
of cannabis.
The terms formerly mentioned that may be used to de-
note various types of cannabis with a precise meaning
shared between researchers and users of cannabis present
with their own limitations. Firstly, it is worth noting that
previous work (Potter and Chatwin 2012) has indicated is-
sues with use of the term ‘skunk’ as identified. As we used
the CEQ, which had already been published and demon-
strated high validity and reliability when administered in
online, student, clinical and non-clinical cohorts (Barkus
et al. 2006; Barkus and Lewis 2008; Stirling et al. 2008;
Quinn et al. 2016), we did not carry out any separate pilot-
ing before initiating the present study. Nevertheless, re-
sults presented here highlight the importance of including
potential respondents in the design of survey questions as
well as piloting survey questions before they go live. Re-
garding the term ‘skunk’, research emerging out of certain
countries such as the USA does not commonly refer to
this term, meaning that concerns about use of this term
may reflect more on UK-based research. Relating to
indica/sativa terms, as highlighted before, focusing on the
physical characteristics of the plant that help distinguish
them may not reliably suggest the plant extract’s biochem-
ical content (Piomelli and Russo 2016) and subsequent
psychological effects. Previous research has suggested that
the morphological distinctions between cannabis plants
may be appropriate for cannabis plant growers interested
in the botanic side (Jikomes 2018) rather than those inves-
tigating the psychological effects of different strains. Sec-
ondly, there is little evidence suggesting a concrete
difference between indica and sativa, with recent evidence
suggesting no distinct genetic difference (Schwabe and
McGlaughlin 2019). Therefore, future research may focus
on relating data from users’ feedback on specific effects
with measurement of the actual THC and CBD concen-
tration in cannabis used by them.
While the current study aimed to solely explore re-
spondents’ feedback regarding cannabis terms, future
work on cannabis experiences should not simply rely on
self-report data. They should formally assess chemical
composition of cannabis used and incorporate this with
contextual information on the purpose of cannabis use
(e.g. whether for ‘medicinal’ or recreational purposes). It
is worth noting that other factors that may influence the
effects of cannabis, such as origin of seed, storage or dis-
tribution methods were not considered in this study.
This was due to the need to identify simple and under-
standable cannabis terms, rather than incorporate all
factors (not raised by respondents) that may affect differ-
ent components of cannabis. Additionally, data was not
collected on where respondents were getting their can-
nabis from. This may have affected responses, as individ-
uals buying cannabis online may be more likely to refer
to specific branded strains, while categories used in re-
search (skunk, oils or resin) may be more relevant to in-
dividuals who use dealers or friends. Therefore, future
work should collect data on where participants’ obtain
their cannabis from to help develop a fuller understand-
ing. There is also a ‘self-selection’ bias, which may have
affected the modest amount of free-text responses pro-
vided, with respondents being more likely to be current
users compared to past cannabis users. Therefore, future
studies looking at self-report data should consider re-
cruitment strategies that ensure a more representative
view of cannabis users and investigate differences be-
tween current and past cannabis users. Lastly, as the ex-
tracted qualitative data was not linked with individual
participant data, it was not possible to examine the fre-
quency of cannabis use specifically within those who
provided a free-text response. Therefore, future work
should investigate whether the terminology reported
here are only preferred by a subgroup of cannabis users
with particular usage patterns.
One of the key strengths of the present study was the
rigorous and transparent methodological procedure used
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to analyse the qualitative data. This increased the con-
textual validity of results, especially due to the small
amount of variance regarding terms mentioned and con-
trasting responses. Therefore, themes could be clearly
coded depending on the cannabis term mentioned and
easily validated through each stage. Secondly, this was
one of the first studies to look into responses to termin-
ology from the perspective of individuals who use canna-
bis frequently, linking to the current importance of
public and patient involvement in research.
Conclusions
In conclusion, this study underscores the importance of in-
corporating views of experienced individuals who frequently
use cannabis on terms currently used to describe cannabis in
research contexts to ensure that assessments use credible
terms, connecting the researcher with users in the general
population. Results presented here indicate a need to move
towards descriptors that incorporate information on the con-
centration of key cannabinoids as well as information on
methods of preparation and consumption.
Abbreviations
THC: Delta-9-tetrahydrocannabinol; CBD: Cannabidoil
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s42238-021-00065-1.
Additional file 1: Appendix 1. Enablers file. Appendix 2. Summarised
analysis file. Appendix 3. Frequency of responses for each cannabis
strain.
Acknowledgements
Dr. Jonathan Newman, University of Sussex.
Authors’ contributions
AM as first author, analysed and interpreted the data, wrote up and modified
the manuscript after edits until its completion. MS recruited participants for
the survey, aided in data analysis and edited the manuscript. CN aided in
data analysis and in editing the first version of the manuscript. SB as
corresponding author recruited participants for the survey and edited the




Availability of data and materials
Summarized data is available from the authors on request, and other results
from this survey have been reported previously (Sami et al. 2019). The
authors do not have ethical approval to provide individual participant data.
Declarations
Ethics approval and consent to participate





The authors declare that they have no competing interests.
Author details
1Department of Psychosis Studies, Institute of Psychiatry, Psychology and
Neuroscience, King’s College London, London SE5 8AF, UK. 2Institute of
Mental Health, University of Nottingham, Triumph Road, Jubilee Campus,
Nottingham, UK. 3School of Medicine Health Policy & Practice, University of
East Anglia, Norwich, UK.
Received: 17 May 2020 Accepted: 29 March 2021
References
Ahmed SA, Ross SA, Slade D, et al. Minor oxygenated cannabinoids from high
potency Cannabis sativa L. Phytochemistry. 2015;117:194–9. https://doi.org/1
0.1016/j.phytochem.2015.04.007.
Barkus E, Lewis S. Schizotypy and psychosis-like experiences from recreational
cannabis in a non-clinical sample. Psychol Med. 2008;38:1267–76.
Barkus EJ, Stirling J, Hopkins RS, Lewis S. Cannabis-induced psychosis-like
experiences are associated with high schizotypy. Psychopathology. 2006;39:
175–8. https://doi.org/10.1159/000092678.
Bhattacharyya S, Morrison PD, Fusar-Poli P, et al. Opposite effects of δ-9-
tetrahydrocannabinol and cannabidiol on human brain function and
psychopathology. Neuropsychopharmacology. 2010;35:764–74. https://doi.
org/10.1038/npp.2009.184.
Bianconi F, Bonomo M, Marconi A, et al. Differences in cannabis-related
experiences between patients with a first episode of psychosis and controls.
Psychol Med. 2016;46:995–1003. https://doi.org/10.1017/S0033291715002494.
Bonn-Miller MO, Boden MT, Bucossi MM, et al. Self-reported cannabis use
characteristics, patterns and helpfulness among medical cannabis users. Am J
Drug Alcohol Abuse. 2014;40:23–30. https://doi.org/10.3109/00952990.2013.
821477.
Budney AJ, Sargent JD, Lee DC. Vaping cannabis (marijuana): parallel concerns to
e-cigs? Addiction. 2015;110:1699–704. https://doi.org/10.1111/add.13036.
Clarke RC, Merlin MD. Cannabis domestication, breeding history, present-day
genetic diversity, and future prospects. CRC Crit Rev Plant Sci. 2016;35(5-6):
293–327. https://doi.org/10.1080/07352689.2016.1267498.
Colizzi M, Bhattacharyya S. Does Cannabis Composition Matter? Differential
Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human
Cognition. Curr Addict Rep. 2017;4:62–74. https://doi.org/10.1007/s40429-017-
0142-2.
Connor JP, Gullo MJ, Feeney GFX, et al. Validation of the Cannabis Expectancy
Questionnaire (CEQ) in adult cannabis users in treatment. Drug Alcohol
Depend. 2011;115:167–74. https://doi.org/10.1016/j.drugalcdep.2010.10.025.
Di Forti M, Marconi A, Carra E, et al. Proportion of patients in south London with
first-episode psychosis attributable to use of high potency cannabis: a case-
control study. Lancet Psychiatry. 2015;2:233–8. https://doi.org/10.1016/S2215-
0366(14)00117-5.
Di Forti M, Morgan C, Dazzan P, et al. High-potency cannabis and the risk of
psychosis. Br J Psychiatry. 2009;195:488–91. https://doi.org/10.1192/bjp.bp.1
09.064220.
Englund A, Freeman TP, Murray RM, McGuire P. Can we make cannabis safer?
Lancet Psychiatry. 2017;4:643–8.
Freeman TP, Winstock AR. Examining the profile of high-potency cannabis and
its association with severity of cannabis dependence. Cambridge University
Press. 2015;45(15):3181–9. https://doi.org/https://doi.org/10.1017/S003329171
5001178.
Hardwick S, King L (2008) Home Office Cannabis Potency Study 2008. Home Office.
Hillig KW, Mahlberg PG. A chemotaxonomic analysis of cannabinoid variation in
Cannabis (Cannabaceae). Am J Bot. 2004;91(6):966–75. https://doi.org/10.3
732/ajb.91.6.966.
Hindocha C, Freeman TP, Schafer G, et al. Acute effects of delta-9-
tetrahydrocannabinol, cannabidiol and their combination on facial emotion
recognition: a randomised, double-blind, placebo-controlled study in
cannabis users. Eur Neuropsychopharmacol. 2015;25:325–34. https://doi.org/1
0.1016/j.euroneuro.2014.11.014.
Holland JG, Torres CA. Lost in translation: an overinterpretation of the acute
effects of cannabinoids. Transl Psychiatry. 2019;9:342. https://doi.org/10.1038/
s41398-019-0669-1.
Mason et al. Journal of Cannabis Research            (2021) 3:12 Page 9 of 10
Iffland K, Grotenhermen F. An update on safety and side effects of cannabidiol: a
review of clinical data and relevant animal studies. Cannabis Cannabinoid
Res. 2017;1:139–54. https://doi.org/10.1089/can.2016.0034.
Jikomes N (2018) Indica, sativa, and ruderalis? Future of cannabis strain classification
| Terpenes and Testing Magazine. https://terpenesandtesting.com/category/
science/classifying-cannabis-strains-designer-cultivars/. Accessed 3 Apr 2019.
Kilmer B, Calkins JP, Midgette G, et al. Before the grand opening: measuring
Washington State’s marijuana market in the last year before legalized
commercial sales. Santa Monica: RAND Corp; 2013.
Leafly. Irvine, California, United States. 2020. http://leafly.com. Accessed 22 Apr 2020.
Morgan CJA, Curran HV. Effects of cannabidiol on schizophrenia-like symptoms in
people who use cannabis. Br J Psychiatry. 2008;192:306–7. https://doi.org/1
0.1192/bjp.bp.107.046649.
Neale J. Iterative categorization (IC): A systematic technique for analysing qualitative
data. Addiction. 2016;111:1096–106. https://doi.org/10.1111/add.13314.
Piomelli D, Russo EB. The Cannabis sativa Versus Cannabis indica debate: an
interview with Ethan Russo, MD. Cannabis Cannabinoid Res. 2016;1:1. https://
doi.org/10.1089/can.2015.29003.ebr.
Potter DJ, Clark P, Brown MB. Potency of Δ9-THC and other cannabinoids in
cannabis in England in 2005: Implications for psychoactivity and
pharmacology. J Forensic Sci. 2008;53:90–4. https://doi.org/10.1111/j.1556-402
9.2007.00603.x.
Potter GR, Chatwin C. The problem with “skunk.”. Drugs Alcohol Today. 2012;12:4.
https://doi.org/10.1108/17459261211286645.
Quinn CA, Wilson H, Cockshaw W, Barkus E, Hides L. Development and validation
of the cannabis experiences questionnaire - Intoxication effects checklist
(CEQ-I) short form. Schizophr Res. 2016;189:91–6. https://doi.org/10.1016/j.
schres.2017.01.048.
Quinn CA, Wilson H, Cockshaw W, et al. Development and validation of the
cannabis experiences questionnaire – Intoxication effects checklist (CEQ-I) short
form. Schizophr Res. 2017;189:91–7. https://doi.org/10.1016/j.schres.2017.01.048.
Radwan MM, ElSohly MA, El-Alfy AT, et al. Isolation and pharmacological
evaluation of minor cannabinoids from high-potency cannabis sativa. J Nat
Prod. 2015;78:1271–6. https://doi.org/10.1021/acs.jnatprod.5b00065.
Sami M, Notley C, Kouimtsidis C, Lynskey M, Bhattacharyya S. Psychotic-like
experiences with cannabis use predict cannabis cessation and desire to quit:
a cannabis discontinuation hypothesis. Psychol Med. 2019;49(1):103–12.
https://doi.org/10.1017/S0033291718000569.
Schoeler T, Petros N, Di Forti M, et al. Effects of continuation, frequency, and type
of cannabis use on relapse in the first 2 years after onset of psychosis: an
observational study. Lancet Psychiatry. 2016;3:947–53. https://doi.org/10.101
6/S2215-0366(16)30188-2.
Schoevers J, Leweke JE, Leweke FM. Cannabidoil as a treatment option for
schizophrenia: recent evidence and current studies. Curr Opin Psychiatry.
2020;33(3):185–91. https://doi.org/10.1097/YCO.0000000000000596.
Schwabe A, McGlaughlin M. Genetic tools weed out misconceptions of strain
reliability in Cannabis sativa: implications for a budding industry. J Cannabis
Res. 2019;1(3):1–16. https://doi.org/10.1186/s42238-019-0001-1.
Stevens A. My cannabis, your skunk: Reader’s response to ‘the cannabis potency
question.’. Drugs Alcohol Today. 2007;7(3):13–7.
Stirling J, Barkus EJ, Nabosi L, Irshad S, Roemer G, Schreudergoidheijt B, et al.
Cannabis-induced psychotic-like experiences are predicted by high
schizotypy: Confirmation of preliminary results in a large cohort.
Psychopathology. 2008;41:371–8.
Stogner JM, Miller BL. Assessing the dangers of “Dabbing”: mere marijuana or
harmful new trend? Pediatrics. 2015a;136(1):1–3. https://doi.org/10.1542/
peds.2015-0454.
Stogner JM, Miller BL. The dabbing dilemma: a call for research on butane hash
oil and other alternate forms of cannabis use. Subst Abus. 2015b;36:393–5.
https://doi.org/10.1080/08897077.2015.1071724.
World Drug Report. United Nations Office on Drugs and Crime; Cannabis and
Hallucinogens, Chapter 5. United Nations publication, Sales No. E.19.XI.8.
2020.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Mason et al. Journal of Cannabis Research            (2021) 3:12 Page 10 of 10
